RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)

One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving the m-RNA COVID-19 (Pfizer-BioNTech) vaccine, the patient admitted with weakness and jaundice for the last three days. Laboratory results are...

Descripción completa

Detalles Bibliográficos
Autores principales: YILMAZ, Fatma, ALBAYRAK, Murat, ARAS, Merih REİS, MARAL, Senem, AFACAN ÖZTÜRK, Hacer Berna, TIĞLIOĞLU, Pınar, TIĞLIOĞLU, Mesut, SAĞLAM, Buğra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2021
Materias:
Pp 47
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572566/
http://dx.doi.org/10.1016/j.htct.2021.10.1057
_version_ 1784595239190659072
author YILMAZ, Fatma
ALBAYRAK, Murat
ARAS, Merih REİS
MARAL, Senem
AFACAN ÖZTÜRK, Hacer Berna
TIĞLIOĞLU, Pınar
TIĞLIOĞLU, Mesut
SAĞLAM, Buğra
author_facet YILMAZ, Fatma
ALBAYRAK, Murat
ARAS, Merih REİS
MARAL, Senem
AFACAN ÖZTÜRK, Hacer Berna
TIĞLIOĞLU, Pınar
TIĞLIOĞLU, Mesut
SAĞLAM, Buğra
author_sort YILMAZ, Fatma
collection PubMed
description One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving the m-RNA COVID-19 (Pfizer-BioNTech) vaccine, the patient admitted with weakness and jaundice for the last three days. Laboratory results are consistent with AIHA recurrence. Splenectomy was performed after the patient stabilized with rituximab therapy. Especially newly developed therapeutic agents have a potential risk of new side effects.
format Online
Article
Text
id pubmed-8572566
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Editora Ltda.
record_format MEDLINE/PubMed
spelling pubmed-85725662021-11-08 RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH) YILMAZ, Fatma ALBAYRAK, Murat ARAS, Merih REİS MARAL, Senem AFACAN ÖZTÜRK, Hacer Berna TIĞLIOĞLU, Pınar TIĞLIOĞLU, Mesut SAĞLAM, Buğra Hematol Transfus Cell Ther Pp 47 One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving the m-RNA COVID-19 (Pfizer-BioNTech) vaccine, the patient admitted with weakness and jaundice for the last three days. Laboratory results are consistent with AIHA recurrence. Splenectomy was performed after the patient stabilized with rituximab therapy. Especially newly developed therapeutic agents have a potential risk of new side effects. Published by Elsevier Editora Ltda. 2021-11 2021-11-07 /pmc/articles/PMC8572566/ http://dx.doi.org/10.1016/j.htct.2021.10.1057 Text en Copyright © 2021 Published by Elsevier Editora Ltda. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Pp 47
YILMAZ, Fatma
ALBAYRAK, Murat
ARAS, Merih REİS
MARAL, Senem
AFACAN ÖZTÜRK, Hacer Berna
TIĞLIOĞLU, Pınar
TIĞLIOĞLU, Mesut
SAĞLAM, Buğra
RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title_full RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title_fullStr RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title_full_unstemmed RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title_short RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title_sort recurrent autoimmune hemolytic anemia after mrna covid-19 vaccine (pfizer-biontech)
topic Pp 47
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572566/
http://dx.doi.org/10.1016/j.htct.2021.10.1057
work_keys_str_mv AT yilmazfatma recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech
AT albayrakmurat recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech
AT arasmerihreis recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech
AT maralsenem recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech
AT afacanozturkhacerberna recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech
AT tiglioglupınar recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech
AT tiglioglumesut recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech
AT saglambugra recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech

Ejemplares similares